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Abstract
Infection is a frequent and serious complication following the treatment of hydrocephalus with CSF shunts, with limited
therapeutic options because of biofilm formation along the catheter surface. Here we evaluated the possibility that the sarA
regulatory locus engenders S. aureus more resistant to immune recognition in the central nervous system (CNS) based on its
reported ability to regulate biofilm formation. We utilized our established model of CNS catheter-associated infection,
similar to CSF shunt infections seen in humans, to compare the kinetics of bacterial titers, cytokine production and
inflammatory cell influx elicited by wild type S. aureus versus an isogenic sarA mutant. The sarA mutant was more rapidly
cleared from infected catheters compared to its isogenic wild type strain. Consistent with this finding, several pro-
inflammatory cytokines and chemokines, including IL-17, CXCL1, and IL-1b were significantly increased in the brain
following infection with the sarA mutant versus wild type S. aureus, in agreement with the fact that the sarA mutant
displayed impaired biofilm growth and favored a planktonic state. Neutrophil influx into the infected hemisphere was also
increased in the animals infected with the sarAmutant compared to wild type bacteria. These changes were not attributable
to extracellular protease activity, which is increased in the context of SarA mutation, since similar responses were observed
between sarA and a sarA/protease mutant. Overall, these results demonstrate that sarA plays an important role in
attenuating the inflammatory response during staphylococcal biofilm infection in the CNS via a mechanism that remains to
be determined.
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Introduction
Ventricular shunts have resulted in drastic improvements in
survival and neurologic outcomes in children with hydrocephalus
[1]. However, these shunts can be associated with significant
complications, including infection, reported in 3–20% of children
with catheters in the central nervous system (CNS; [1]). These
infections have been associated with increased mortality rates,
increase seizure risk and IQ loss [2]. Staphylococcus aureus (S. aureus)
and Staphylococcus epidermidis are the most common causes of CNS
shunt infections and both organisms are well known to form
biofilms on catheter surfaces [2,3]. Biofilms are classically resistant
to antibiotic therapy, such that catheter removal is currently
recommended for the treatment of these infections [4].
Very few animal models have been described that investigate
the pathogenesis of biofilm infections within the CNS. Our
laboratory has previously described a mouse model of S. aureus
catheter-associated biofilm infection, which mimics several aspects
of ventricular shunt infections in humans [5]. This model is
typified by innate immune cell influx into the tissue surrounding
the infected catheter, with a concomitant increase in inflammatory
cytokine and chemokine expression compared to sterile catheter
placement [5]. This was similar to the inflammatory phenotype
observed in studies utilizing a steel pin tibial biofilm infection
model [6], but in contrast to the anti-inflammatory immune
response reported in a flank catheter biofilm model, emphasizing
the variability in immune responses to biofilm infection in different
body compartments [7,8,9]. To better elucidate the impact of
biofilm formation on the inflammatory response within the CNS,
we compared our catheter-associated biofilm infection with a
parenchymal brain abscess utilizing the methicillin-susceptible S.
aureus (MSSA) strain ACH 1719. Using the same bacterial strain,
but under different growth modalities, would better define the
inflammatory impact of biofilm versus planktonic infection in the
CNS compartment.
The staphylococcal accessory regulatory (sarA) locus encodes a
DNA-binding protein (SarA) that has a global impact on gene
expression in S. aureus [10–12]. Several studies have demonstrated
that mutation of the sarA locus limits, but does not abolish, the
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ability of most S. aureus strains to form a biofilm and results in
greater susceptibility to anti-staphylococcal antibiotic treatment
[10–12]. With decreased biofilm formation, there is likely a greater
degree of planktonic growth in infected tissues, which would
provide both antibiotics and the immune response increased access
to bacteria compared to a fully intact biofilm. Indeed, we found in
the current study that when compared with both parenchymal
brain abscesses and a sarA mutant, which displayed impaired
biofilm formation in the CNS, catheter-associated biofilm
infections established with wild type S. aureus were significantly
less inflammatory. Specifically, both cytokine and chemokine
levels in the tissues surrounding infected catheters as well as innate
immune cell influx were significantly decreased in the brains of
mice infected with wild type S. aureus that formed a mature biofilm
[5]. These findings were consistent with our prediction that biofilm
growth actively attenuates the CNS host immune response in favor
of bacterial persistence. This builds on findings from our earlier
work, showing inflammation during CNS catheter infection in
comparison to sterile catheters [5], by demonstrating that this
inflammation is due to the parenchymal spread observed during
infection rather than the biofilm. The enhanced CNS inflamma-
tory response observed with the sarA mutant was protease-
independent, since similar inflammatory profiles were elicited
with the sarA and a sarA/protease mutant [13]. These studies
highlight the role of the sarA regulatory locus, which may engender
S. aureus more resistant to CNS immunity based on its ability to
regulate biofilm formation via an undetermined mechanism.
Understanding the role of sarA in CNS catheter infections may
facilitate the identification of viable therapeutic targets for the
treatment of ventricular shunt infections.
Results
S. aureus Catheter-associated Biofilms are Less
Inflammatory than Parenchymal Brain Infection in the
CNS
To delineate potential alterations in the CNS immune response
that occur based on infection modality alone, CNS catheter-
associated infection was compared with a parenchymal brain
abscess using the same S. aureus strain. As previously reported, our
CNS catheter infection model generates a bona fide biofilm, using a
methicillin-susceptible S. aureus (MSSA) clinical strain originally
isolated from a child with a ventriculoperitoneal shunt infection
[5]. This infection elicits pro-inflammatory cytokine and chemo-
kine release in the brain tissue surrounding infected compared to
sterile catheters, although the relative contribution of bacteria
adherent to the catheter versus detached organisms to this
inflammatory response was unclear. Thus, we compared the
intensity of immune responses generated following catheter-
associated biofilm infection to a parenchymal brain abscess using
the same MSSA isolate to allow direct comparisons of the impact
of the infection modality on the inflammatory response within the
CNS.
As observed in brain abscesses generated using other S. aureus
strains [14–16], parenchymal bacterial burdens were initially high
and began to rapidly decline by the first week (Figure 1). In
contrast, during catheter-associated infection, bacterial titers on
the catheter surface remained elevated throughout the course of
infection, reflective of more chronic biofilm formation (Figure 1).
Similar to brain abscesses, bacterial burdens in the tissues
surrounding infected catheters also progressively decreased over
time, reflecting a planktonic growth state under both conditions.
Next, comparisons in proinflammatory cytokine and chemokine
expression between the catheter biofilm and brain abscess
infection models were assessed. Initial examination of raw
cytokine/chemokine values revealed similar CXCL1 and IL-17
expression in both models (Figure 2A and C, respectively)
throughout the course of infection despite the dramatic differences
in total bacterial burdens (Figure 1). To evaluate the proportional
impact of the total bacterial burden in either the planktonic or
biofilm infection model on inflammatory mediator production,
cytokine and chemokine levels were adjusted based on total
bacterial titers. After this normalization, CXCL1 and IL-17 were
significantly decreased during biofilm infection compared to
planktonic abscesses (Figure 2B and D, respectively). A similar
trend was observed with IL-1b, with significantly increased levels
observed in brain abscess tissues versus catheter-associated biofilm
infection (data not shown). Collectively, these findings suggest that
biofilms elicit less inflammation than a planktonic infection within
the CNS compartment using the MSSA strain examined here.
sarA is Critical for CNS Catheter-associated Biofilm
Formation
The staphylococcal accessory regulatory (sarA) locus encodes a
DNA-binding protein (SarA) that has a global impact on gene
expression in S. aureus [10–12]. Several studies have demonstrated
that mutation of the sarA locus limits, but does not abolish, the
ability of most S. aureus strains to form a biofilm and results in
greater susceptibility to anti-staphylococcal antibiotic treatment
[10–12]. Importantly, strain-dependent differences among S. aureus
isolates that affect biofilm phenotypes have been reported
[12,17,18], so assessing the ability of the sarA mutant in the
ACH1719 MSSA background to form a biofilm was essential
[12,17,18]. To evaluate biofilm formation, ACH1719DsarA was
compared with its isogenic wild type strain ACH1719, as well as
two other S. aureus strains known to be effective biofilm producers,
using an in vitro microtiter plate assay as well as confocal
microscopy analysis. As expected, both of these assays demon-
strated decreased biofilm development in ACH1719 DsarA in
comparison to wild type ACH1719 (Figure S1).
To determine whether genes regulated by the sarA operon were
involved in the diminished immune response during catheter-
associated biofilm infections (Figure 2), we compared the course of
CNS catheter-associated biofilm infection using wild type
ACH1719 and ACH1719DsarA. Mice were observed following
the surgical procedure for weight loss, clinical indices of infection,
seizure activity and mortality. Mice infected with wild type
ACH1719 had less weight loss and lower mortality rates than
animals infected with ACH1719DsarA (15.9% 61.3% vs 22.2%
61.5% p,0.006 and 23% 64.9% vs 29.8% 66% n.s.,
respectively). This is in contrast to prior studies using sarA-
deficient S. aureus in other infection models, in which a sarA mutant
was less virulent than the wild type strain [19,20]. This difference
in virulence emphasizes the importance of evaluating host-
pathogen interactions in multiple tissue compartments, as areas
such as the CNS may respond differently to infection than
peripheral sites, although strain background differences cannot be
discounted. Both groups exhibited similar frequencies in seizure
activity during the second week post-infection, with spontaneous
recovery to baseline following these episodes.
As expected based on our in vitro studies, ACH1719 DsarA
displayed impaired catheter-associated biofilm growth compared
to its isogenic wild type strain (Figure 3). This diminished biofilm
formation is consistent with observations in other animal models of
sarA-deficient S. aureus infection [11,19,20] and our in vitro assays
(Figure S1). Additionally, mice infected with ACH1719 DsarA
demonstrated higher rates of bacterial clearance, with 43% (10/
23) of animals having no discernible bacterial growth on catheters
sarA Regulates Brain Catheter Colonization
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at day 14, versus 15% (2/13) of those infected with wild type
ACH1719. There was no evidence of bacterial spread to either the
contralateral brain hemisphere or peripheral organs in either wild
type or ACH1719 DsarA (data not shown). Finally, there were no
significant differences in bacterial burdens in the surrounding
brain parenchyma between wild type and ACH1719 DsarA
infected mice at any time point examined (Figure S2).
sarA Mutation Leads to Heightened Proinflammatory
Responses during CNS Catheter-associated Infection
To evaluate whether sarA expression, and indirectly biofilm
growth, attenuates pro-inflammatory mediator production during
CNS catheter infection, homogenates of catheter-associated tissues
were analyzed for IL-1b and CXCL1 production by ELISA.
When adjusted to account for the divergent bacterial burdens
between the two strains, both mediators were significantly elevated
in response to ACH1719 DsarA compared to WT bacteria
(Figure 4). A similar pattern was seen with IL-17, with significantly
elevated production during ACH1719 DsarA infection (data not
shown). These findings are consistent with cytokine/chemokine
analysis of catheter-associated versus parenchymal brain abscess
infection (Figure 2), reinforcing the concept that the ability to form
a biofilm is inherently anti-inflammatory in the CNS.
Given the elevated levels of pro-inflammatory cytokines
associated with the ACH1719 DsarA strain, a concomitant increase
in innate immune cells was expected. To quantitate innate
immune cell influx, catheter-associated leukocytes were recovered
using a Percoll gradient method and analyzed by FACS. A trend
towards increased numbers of neutrophils, macrophages and T
lymphocytes were observed following infection with the biofilm-
deficient ACH1719 DsarA strain compared to wild type S. aureus,
although these differences did not reach statistical significance
(Figure 5, Figure S3), which correlated with enhanced chemokine
expression (Figure 4).
sarA Mutation Leads to Decreased a-toxin Production
during CNS Catheter-Associated Infection
Prior studies have reported decreased a-toxin production by
certain S. aureus USA300 sarA mutant strains in vitro and in vivo
[13,21,22]. This is thought to result from increased production of
extracellular proteases in sarA-deficient strains of staphylococci,
leading to decreased accumulation of a-toxin as well as phenol
soluble modulins (PSMs) [22]. However, other studies in
laboratory-derived strains have demonstrated an opposite or no
effect on a-toxin production in S. aureus sarA mutants [17,22]. As a-
toxin can be an inflammatory stimulus within the brain [23,24],
evaluating a-toxin production by this staphylococcal strain in vivo
was assessed. As observed in other S. aureus clinical isolates, animals
infected with ACH1719 DsarA demonstrated decreased levels of a-
toxin at days 1 and 3 following infection (Figure 6). Later time
points were not examined as bacterial burdens were declining in
the tissue and a-toxin expression was expected to be below the
threshold of detection based on other studies of staphylococcal
infection in the brain (T Kielian, unpublished data). Given the
pro-inflammatory nature of a-toxin, it was expected that
inflammatory mediator expression would be higher in tissues
associated with the wild type ACH1719 strain compared to
ACH1719 DsarA, since the former displayed elevated a-toxin
levels. However, the opposite relationship was observed (Figure 4),
suggesting that the increased inflammation associated with the sarA
mutant cannot be attributed to alterations in a-toxin levels in the
surrounding tissue.
The Heightened CNS Inflammatory Response Elicited by
a sarA Mutant is Largely Protease-independent
Mutation in the sarA regulatory locus has been shown to have
broad effects on several staphylococcal virulence factors, including
decreased accumulation of a-toxin, decreased PSMs and increased
Figure 1. MSSA CNS catheter-associated biofilm infection persists longer than a parenchymal brain abscess. The infected tissue was
removed, homogenized and cultured to enumerate bacterial burdens in the tissue containing the brain abscess or surrounding the infected catheter.
Catheters were also removed, rinsed and sonicated for quantification of viable bacteria. * = p,0.05 (n = 12–18 mice/group/time point).
doi:10.1371/journal.pone.0084089.g001
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extracellular protease activity [13,22,25]. As noted above, the
decrease in a-toxin accumulation cannot account for the
heightened inflammatory profile observed in vivo during CNS
infection. Similarly, as PSMs have also been demonstrated to be
pro-inflammatory, decreased PSM production in staphylococcal
sarA mutants should result in decreased inflammation rather than
then increase observed in these studies [26,27]. The third major
virulence factor affected by sarA mutation in S. aureus are the
extracellular proteases aureolysin (Aur), staphylococcal serine
glutamyl endopeptidase A (SspA/V8) and its co-transcribed
cysteine peptidase (SspB) and staphopain (ScpA), all of which
are increased in the absence of sarA regulation [13,18,28]. To
define the potential impact of altered protease production by the
sarA mutant during CNS catheter infection, we compared the
inflammatory profile of mice infected with a wild type USA300
LAC S. aureus strain with isogenic mutants deficient in sarA alone
(SarA-deficient), the four major extracellular proteases described
above (protease-deficient) and both sarA and the extracellular
proteases (SarA-protease-deficient) [13]. This approach also
allowed us to confirm the altered inflammatory phenotype
observed with MSSA (ACH1719) versus MRSA (USA300 LAC)
S. aureus isolates. At days 3 and 7 post-infection, all strains
demonstrated significantly more bacteria associated with the
catheter than the surrounding parenchyma, consistent with the
above experiments with the MSSA strain ACH1719 (data not
shown). Both the protease-deficient and sarA-protease deficient
MRSA strains displayed greater biofilm formation, as evidenced
by greater numbers of bacteria cultured from the catheters, at day
3 in congruence with prior reports of these mutants in peripheral
infection models (Figure 7) [13]. This effect was transient and
dissipated by day 7, suggesting that the impact of extracellular
proteases is greatest during acute CNS catheter infection.
Evaluation of CNS parenchymal titers revealed no dramatic
differences between the WT or its isogenic mutants (Figure S4).
To evaluate whether extracellular proteases, in conjunction with
or independent of broader sarA effects, affect pro-inflammatory
mediator production during CNS catheter infection, homogenates
of catheter-associated tissues were analyzed for IL-1b and CXCL1
production by ELISA. When adjusted to account for divergent
bacterial burdens, both mediators were significantly elevated in
mice infected with the SarA- and SarA-protease-deficient MRSA
strains in comparison with the wild type and protease-deficient
MRSA strains (Figure 8). This relationship was also observed
when measuring IL-17 levels (data not shown). This suggests that
Figure 2. CNS catheter-associated biofilm infection is associated with attenuated inflammation compared to parenchymal
abscesses. The tissues encompassing the brain abscess and the tissues surrounding the infected catheters were homogenized and the resulting
supernatants analyzed for levels of the pro-inflammatory mediators CXCL1 (A, B) and IL-17 (C, D). Raw cytokine/chemokine levels are reported (A, C)
as well as correction for disparate bacterial burdens (B, D) * = p,0.05 (n = 12–18 mice/group/time point).
doi:10.1371/journal.pone.0084089.g002
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the heightened inflammation observed following CNS infection
with a sarA mutant cannot be attributed to alterations in protease
activity, given the increased inflammation observed in response to
infection with the SarA-protease-deficient strain versus the
protease-deficient strain.
Discussion
Cerebrospinal fluid shunt infections are a frequent complication
of hydrocephalus treatment, with significant associated costs in
both medical expense and patient morbidity [2,29]. These
infections can cause shunt failure, increased seizure risk, decreased
intellectual performance and increased mortality [2]. Because it is
difficult to treat these catheter-associated biofilm infections in the
brain, current guidelines recommend removal of the infected
shunt, resulting in additional surgical procedures and extended
hospital stays for affected children [4]. Thus, a better understand-
ing of host-pathogen interactions is crucial to guide new treatment
options for these CNS catheter infections.
Our recent studies using this murine model demonstrated a
reproducible catheter-associated infection, with scanning electron
microscopy findings consistent with biofilm formation [5]. In
addition, increases in pro-inflammatory cytokines and chemokines
were detected in the tissue surrounding infected catheters, as well
as enhanced innate immune cell influx. These comparisons were
made to responses elicited by sterile catheters, which allowed an
important assessment of the injury/foreign body response. In the
current study, we have defined these inflammatory changes in
comparison to a planktonic infection (i.e. brain abscess), to better
delineate the relative contribution of the biofilm itself to the CNS
immune response. Here we report that catheter-associated biofilms
are less inflammatory than planktonic infections, as evidenced by
the fact that pro-inflammatory cytokine and chemokine expression
was significantly reduced in animals with catheter infections
caused by wild type S. aureus compared to brain abscesses induced
by the same strain. This is consistent with the anti-inflammatory
phenotype described in a peripheral model of S. aureus catheter-
associated infection in the flank, in which the biofilm was found to
induce lower levels of cytokines and chemokines than expected [7].
This diminished inflammatory response may play a role in the
persistence of these infections, as effective immune clearance of the
bacteria is impaired by the biofilm.
We next utilized a staphylococcal strain with a mutation in the
regulator sarA as a tool to further explore the mechanisms
responsible for this attenuated inflammatory response. A S. aureus
sarA mutant was chosen as a representative-biofilm deficient strain
because it has demonstrated decreased biofilm formation in vivo in
multiple animal models of infection [10–12]. Using a SarA-
deficient MSSA mutant (DsarAACH1719), we observed a similar
increase in inflammatory mediators during CNS catheter infection
as was seen in the parenchymal brain abscesses, when compared
with wild type catheter-associated infection. SarA is an important
staphylococcal regulator, with broad effects, including control of
several key virulence factors [10–12,19], including decreased
accumulation of a-toxin and PSMs in sarA mutants [13,21,22,24–
27,30]. Based on the pro-inflammatory properties of both a-toxin
and PSM, the decreased accumulation of these factors in sarA
mutants should result in decreased inflammation rather than the
increase observed in these studies. SarA-deficient staphylococcal
strains have also been shown to have increases in the extracellular
proteases Aur, SspA, and its co-transcribed SspB, and ScpA
[13,18,28]. Alterations in extracellular proteases have been shown
in vitro and in vivo to result in an increase in biofilm accumulation,
as confirmed by the increased catheter-associated bacterial
burdens in the protease-deficient and SarA-protease-deficient
MRSA strains observed in the central nervous system in these
Figure 3. sarA is critical for catheter-associated biofilm formation in a CNS catheter infection model. Infected catheters were removed,
rinsed and sonicated for quantification of viable bacteria associated with wild type ACH1719 (WT) or ACH1719DsarA (DsarA) S. aureus. At all time
points, bacterial burdens in brain parenchyma were lower than the corresponding catheter cultures (See Figure S2). *=p,0.05 WT catheter vs DsarA
catheter; (n = 11–21 mice/group/time point).
doi:10.1371/journal.pone.0084089.g003
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experiments [13,31]. However, little is known about the impact of
increased protease production on the immune response to
infection. By comparing levels of pro-inflammatory mediators in
the CNS tissue surrounding the catheters infected with wild type,
SarA-deficient, protease-deficient and SarA-protease-deficient
MRSA strains, we were able to demonstrate that the increase in
inflammation observed in infections with sarA mutants was
independent of extracellular protease activity. Effects of sarA
beyond regulation of these virulence determinants needs to be
further explored to determine the specific mechanisms responsible
for this attenuated CNS immune response.
Interactions between staphylococcal biofilms and the host
immune response remain to be fully defined in either the CNS
or the periphery. Both TLR2 and TLR9 ligands are known to be
present in biofilms, yet the absence of neither receptor impacted
biofilm growth in an in vivo model of S. aureus catheter-associated
infection in the flank, suggesting there are redundant mechanisms
available to assist the biofilm in evading the immune response [7].
Later studies in this model suggest that MyD88 signaling is needed
for early containment and regulation of the macrophage response
in biofilm infections, as lack of MyD88 signaling augmented
polarization toward an anti-inflammatory M2 macrophage
response [8]. Further demonstrating the complexity of host-
pathogen interactions in vivo, a staphylococcal post-surgical joint
infection model showed that IL-1b appeared to play a protective
role in this setting through neutrophil recruitment, which also
requires MyD88 for signaling via IL-1RI [32]. Other studies using
a bone pin biofilm infection model have demonstrated a skewed
immune response in which mice with a Th1-predominant
phenotype are more easily infected and those with Th2-
predominant phenotype easily clear infection, suggesting that the
immune response to a biofilm is distinct from that of a
parenchymal infection [6]. This has been demonstrated in vitro
as well, with decreased macrophage phagocytosis of both S. aureus
and S. epidermidis biofilms [7,33]. Additionally, in vitro experiments
with S. epidermidis found that macrophages were less pro-
inflammatory when co-cultured with biofilm-capable versus
biofilm-impaired strains of bacteria [33], similar to the results
seen in our in vivo experiments comparing wild type S. aureus versus
the biofilm-impaired sarA mutant strain of S. aureus. Collectively,
these studies and our own work suggest that interactions between
the host and staphylococcal biofilms are complex, with alterations
in the immune response favoring bacterial persistence. Further
work is needed to define the mechanisms responsible for this
Figure 4. sarA dictates the extent of proinflammatory mediator expression during CNS catheter-associated infection. Catheter-
associated infections were generated with either wild type ACH1719 (WT) or ACH1719DsarA (DsarA). The tissue surrounding the infected catheters
was homogenized and the resulting supernatant analyzed for levels of the pro-inflammatory mediators CXCL1 (A, B) and IL-1b (C, D). Results are
presented as raw data (A and C) and after adjustment for divergent bacterial burdens (B and D). * = p,0.05 (n = 11–21 mice/group/time point).
doi:10.1371/journal.pone.0084089.g004
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depressed immune response. To further explore the mechanisms
of immune evasion in biofilm infection, we are currently adapting
this CNS catheter infection model to generate infection with S.
epidermidis, as we would expect the immune dampening to be more
pronounced in infections with an organism with a more limited
array of virulence factors [34–36].
Alterations in SarA have been extensively explored, as this
presents a potential therapeutic target for treatment of staphylo-
coccal disease given the important role of SarA in defining
virulence. Several studies have demonstrated that infections
caused by sarA-deficient strains of S. aureus are more susceptible
to antimicrobial treatment compared to wild type strains,
including subcutaneous catheter and endocarditis models
[11,20]. Given the enhanced inflammatory responses and bacterial
clearance observed in our CNS catheter model following DsarA
infection, it is reasonable to suspect that SarA inactivation also
renders the biofilm more susceptible to immune clearance. This
may further support the potential of SarA as a therapeutic target
for the treatment of staphylococcal device infections. However,
care must taken when evaluating this treatment in the CNS, given
the increased mortality rate observed in response to DsarA in our
experiments. This increased mortality may be mitigated by the
addition of antibiotic therapy, given the increased response to
antibiotics noted in other models testing sarA-deficient S. aureus
strains; however, this needs to be carefully evaluated in the CNS
[11,20].
The decreased inflammatory response to biofilm infections in
the CNS may explain the bacterial persistence and resultant
difficulty in treating these infections in children. A better
understanding of the complex interactions between the immune
system and the biofilms that form along catheters in the brain
could provide valuable information for screening patients at high
risk for infections and for providing adjunctive therapy to current
antibiotic treatment recommendations. The high costs to these
children and their families in healthcare expenses and patient
morbidity make new treatment and diagnostic modalities imper-
ative for patients with CNS catheter infections.
Figure 5. sarA influences peripheral immune cell influx during CNS catheter-associated infection. Catheter associated cells were
recovered from mice at days 3, 7 and 14 post-infection, whereupon pooled tissue from 4–5 mice per group (wild type ACH1719– WT vs
ACH1719DsarA – DsarA) was analyzed for neutrophil (A), macrophage (B) and T cell (C) infiltrates, with three independent replicates. Data was
corrected for bacterial burdens at each time point. See Figure S2 for representative histograms.
doi:10.1371/journal.pone.0084089.g005
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Figure 6. a-toxin levels are reduced during CNS catheter-associated infection with a sarA mutant. Alpha-toxin levels were measured in
brain homogenates of animals infected with the ACH1719 sarA mutant (DsarA) or wild type ACH1719 strain (WT) at the indicated time points post-
infection using a custom-designed ELISA. * = p,0.05 (n = 13–15 mice/group/time point).
doi:10.1371/journal.pone.0084089.g006
Figure 7. sarA and extracellular proteases significantly affect biofilm formation in a CNS catheter infection model. Infected catheters
were removed, rinsed and sonicated for quantification of viable bacteria associated with wild type USA300 LAC (WT catheter), USA300 LACDsarA
(SarA-deficient catheter), extracellular protease deficient USA300 LAC (Protease-deficient catheter), or SarA and extracellular protease
deficient (SarA-Protease-deficient catheter) S. aureus. At all time points, bacterial burdens in brain parenchyma were 3–5 log lower than the
corresponding catheter cultures (See Figure S4). a=p,0.05 WT vs SarA-deficient catheter; b=p,0.05 WT vs Protease-deficient catheter;
c=p,0.05 WT vs SarA-Protease-deficient catheter; d=p,0.05 SarA-deficient vs Protease-deficient catheter; e= SarA-deficient vs SarA-Protease-
deficient catheter; f= SarA-Protease-deficient vs Protease-deficient catheter (n = 13–15 mice/group/time point).
doi:10.1371/journal.pone.0084089.g007
sarA Regulates Brain Catheter Colonization
PLOS ONE | www.plosone.org 8 December 2013 | Volume 8 | Issue 12 | e84089
Materials and Methods
Ethics Statement
This study was conducted in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the Institutional Animal Care and Use
Committee of the University of Nebraska Medical Center
(Approval IDs: 09-053-08-FC and 11-012-04-FC). All surgery
was performed under ketamine/xylazine anesthesia, and every
effort was made to minimize suffering.
Mice
Male C57BL/6 mice (The Jackson Laboratory, Bar Harbor,
ME; 8 weeks of age) were used for all studies. Each experiment was
performed independently at least three times, with a minimum of
4–5 mice per experimental group at each time point.
Bacterial Strains
Brain abscess and catheter-associated infections were generated
using a MSSA strain obtained from a ventriculo-peritoneal shunt
infection of a pediatric patient at Arkansas Children’s Hospital
(ACH 1719), or its isogenic mutant missing the sarA regulator. This
sarA mutant was kindly generated by the laboratory of Dr. Mark
Smeltzer (University of Arkansas for Medical Sciences, Little
Rock, AR) via Q-mediated transduction as previously described
[37]. Additional catheter-associated infections were generated
using USA300 LAC and its isogenic mutants lacking the sarA
regulator, genes encoding the extracellular proteases (aur, scpA,
splABCDEF, sspAB) or both sarA and the extracellular protease
genes [13,38]. For in vitro assays, UAMS-1 and USA300 LAC
were also used for comparison as these are well-established
biofilm-forming clinical isolates [7,19,39].
CNS Catheter-associated Biofilm Infection
Silicone catheters were pre-coated with normal mouse serum
and incubated with either 103 cfu/ml ACH1719 WT or 26104
cfu/ml ACH1719 DsarA for 4 h to facilitate bacterial attachment
Figure 8. Inflammatory mediators are elevated in response to infection with sarA and sarA-protease mutants independently of
protease activity. Catheter-associated infections were generated with wild type USA300 LAC (WT catheter), USA300 LACDsarA (SarA-deficient
catheter), extracellular protease deficient USA300 LAC (Protease-deficient catheter), or SarA and extracellular protease deficient (SarA-
Protease-deficient catheter) S. aureus. The tissue surrounding the infected catheters was homogenized and the resulting supernatant analyzed for
levels of the pro-inflammatory mediators CXCL1 (A, B) and IL-1b (C, D). Results are presented as raw data (A and C) and after adjustment for divergent
bacterial burdens (B and D). * = p,0.05 (n = 13–15 mice/group/time point).
doi:10.1371/journal.pone.0084089.g008
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(final bacterial burdens adherent to the catheter were 76102 cfu
636102 and 3.56103 cfu 68.76103 respectively). A larger initial
bacterial burden in mice infected with ACH1719 DsarA was
chosen given its decreased ability to form sustained biofilm
infection as reported by others [11,12,19]. Catheters were rinsed
and implanted intracerebrally into the lateral ventricle of mice
using a stereotactic apparatus as previously described [5]. Briefly,
mice were anesthetized with i.p. injections of ketamine and
xylazine (100–200 mg/kg and 5–16 mg/kg respectively) and a
1 cm longitudinal incision was made in the scalp to expose the
underlying skull sutures. A rodent stereotaxic apparatus equipped
with a Cunningham mouse adaptor was used to implant S. aureus-
coated catheters into the lateral ventricle using the following
coordinates relative to bregma: +0.2 mm rostral, +1 mm lateral
and 22 mm deep. A burr hole was made at these coordinates and
the catheter gently inserted until it was level with the skull surface.
The burr hole was sealed with bone wax to minimize bacterial
efflux and bleeding. The skin incision was closed using surgical
glue and the animals monitored over the post-operative course for
clinical signs of infection or any post-operative complications. All
animals survived the procedure, with mortality rates of 24% and
35% for the wild type and ACH1719 DsarA infected animals,
respectively. Prior studies have demonstrated that animals
implanted with sterile catheters survive the procedure and post-
operative course indefinitely, with no mortality attributable to the
catheter implantation [5]. Animals that survived long-term were
sacrificed at the indicated intervals post-infection for evaluation of
bacterial burdens and inflammatory indices. Data from any
animal with negative bacterial cultures at the time of sacrifice,
suggesting spontaneous resolution of infection or failure to
establish infection, were excluded from further analysis.
Generation of Experimental Brain Abscesses
Brain abscesses were induced by stereotactic injection of 104 cfu
S. aureus strain ACH1719 encapsulated in agarose beads into the
striatum as previously described [14,15]. The procedure was well-
tolerated by all animals with a mortality rate ,5% over the course
of infection. All mice survived the procedure indefinitely and were
sacrificed at the indicated time points to evaluate bacterial burdens
and inflammatory indices. Data from any animal with negative
bacterial cultures at the time of sacrifice, suggesting spontaneous
resolution of infection or failure to establish infection, were
excluded from further analysis.
Generation of S. aureus Biofilms in vitro
To assess the ability of the ACH1719 sarA mutant to form a
biofilm, overnight cultures of USA300 LAC, UAMS-1, MSSA
ACH1719 and MSSA ACH1719 DsarA were incubated with TSB
in a 96-well polystyrene microtiter plate pre-coated with mouse
serum. After a 24 h incubation period and rinsing, the remaining
biofilm was fixed with 100% EtOH and stained with 0.41% crystal
violet for visualization [5,19]. For confocal microscopy analysis,
static biofilms were grown on sterile glass chamber slides (Fisher
Scientific, Houston TX) treated with 20% human plasma
(generous gift of Dr. Steve Carson, UNMC) in sterile carbonate-
bicarbonate buffer overnight [40]. The plasma coating buffer was
removed and each chamber inoculated with 2 ml ACH1719 or
ACH1719 DsarA in TSB. Slides were incubated at 37uC under
static aerobic conditions for 2 days and stained with Syto9 (1:100
dilution in PBS; Invitrogen, Carlsbad CA) for visualization of the
biofilm using a Zeiss laser scanning confocal microscope (Zeiss
LSM 510, Oberkochen, Germany).
Enumeration of Viable Bacteria from CNS Tissue and
Catheters
Catheters and surrounding brain tissues were recovered from
infected mice at days 3, 5, 7, 10 and 14 following infection. Brain
tissues were homogenized for bacterial titer determination and
inflammatory mediator measurement as previously described,
allowing for quantitative culture and cytokine analysis from a
single animal [41]. Briefly, catheters were removed and the
surrounding brain tissue was sectioned within 1–2 mm on all sides.
Catheters were removed from the brain tissue, rinsed in PBS to
remove any non-adherent bacteria and sonicated in 500 ml of
PBS. This solution was then serially diluted and cultured on tryptic
soy agar (TSA) plates supplemented with 5% sheep blood as
previously described [5,10]. Brain tissues were homogenized in
500 ml sterile phosphate-buffered saline (PBS) supplemented with
a complete protease inhibitor cocktail tablet (Roche, Basel
Switzerland) and RNase inhibitor (Promega, Madison WI) using
a Polytron homogenizer (Brinkmann Instruments, Westbury NY).
A 20 ml aliquot was removed for culture via serial dilutions on agar
plates as described above. The remaining slurry was centrifuged
and the supernatant collected and stored at 280C until cytokine/
chemokine analysis.
ELISAs
Inflammatory mediators (IL-1b, IL-17, and CXCL1) were
measured in brain tissue homogenates using commercially
available ELISA kits according to the manufacturer’s instructions
(R&D Systems, Minneapolis MN). Results were normalized to
total bacterial titers of each tissue to correct for differences in
bacterial burdens between wild type and mutant strains. Alpha
toxin levels were measured using a custom-designed ELISA
protocol. Briefly, wells of an ELISA microtiter plate were coated
with purified a-toxin (Toxin Technologies, Sarasota FL) diluted in
carbonate/bicarbonate buffer (pH 9.6) to generate a standard
curve. The remaining wells were coated with the sample (100 mL
per well) and incubated overnight at 4uC. The plates were washed
and then blocked with 10%FBS/PBS for 2 h at room temperature
(200 mL per well). After washing, wells were then incubated with a
rabbit anti-a-toxin antibody (Sigma Aldrich, St. Louis MO) for
1 hour at room temperature (100 mL per well). The wells were
again washed, whereupon 100 mL per well of an anti-rabbit IgG-
HRP secondary Ab was added (Sigma Aldrich, St. Louis MO) for
1 h at room temperature. Following this incubation, the wells were
washed, incubated for 15–20 min with TMB substrate in the dark
until color development, and read using a plate reader at 450 nm
Ex/575 nm Em.
Quantitation of Immune Cell Infiltrates in Brain Tissues
Catheter-associated cells were recovered from the brain
parenchyma for quantitation by FACS analysis as previously
described [14,15]. Briefly, mice were perfused to eliminate
leukocytes from the vasculature and the entire infected hemisphere
was removed to recover catheter-associated cells. Brain tissues
were minced and gently filtered through a 70 mm nylon mesh
strainer. The resulting slurry was subjected to collagenase/DNAse
digestion to facilitate immune cell retrieval, and then centrifuged
on a discontinuous Percoll gradient to remove myelin debris.
Recovered cells were incubated in Fc BlockTM (BD Biosciences,
San Diego CA) to minimize non-specific antibody binding to Fc
receptors and then stained with directly conjugated antibodies for
FACS to detect neutrophils (Ly-6G+, CD11b+, CD45hi), macro-
phages (Ly-6G2, CD11b+, CD45hi), microglia (Ly-6G2, CD11b+,
CD45lo-intermediate) and T lymphocytes (CD3+). All antibodies were
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purchased from BD Biosciences. Cells were analyzed using a BD
FACSAria with compensation set based on the staining of each
individual fluorochrome alone and correction for autofluorescence
with unstained cells. Results were corrected based on catheter-
associated bacterial titers to account for burden disparities
between the ACH1719 wild type and ACH1719 DsarA strains.
Statistics
Significant differences between experimental groups were
determined using the unpaired Student t-test at the 95%
confidence interval with Sigma Stat (SPSS Science, Chicago IL).
Supporting Information
Figure S1 ACH1719DsarA displays impaired biofilm
formation in vitro. The ability of ACH1719DsarA, wild type
ACH1719, USA300 LAC, and UAMS-1 to establish a biofilm was
determined using an in vitro microtiter plate assay with crystal
violet staining (A) and confocal microscopy where bacteria were
cultured on a glass chamber slide and stained with Syto9 (B).
(TIF)
Figure S2 sarA exerts no significant effect on parenchy-
mal spread of CNS infection. The infected tissue was
removed, homogenized and cultured to enumerate the bacterial
burdens in the tissue surrounding the catheter infected with either
wild type ACH1719 (WT) or ACH1719DsarA (DsarA) S. aureus.
Catheters were also removed, rinsed and sonicated for quantifi-
cation of viable bacteria. a=p,0.05 WT brain vs catheter;
b=p,0.05 DsarA brain vs catheter; c=p,0.05 WT catheter vs
DsarA catheter; (n = 11–21 mice/group/time point).
(TIF)
Figure S3 There is a trend toward increased peripheral
immune cell influx during CNS catheter-associated
infection in the absence of sarA. Catheter associated cells
were recovered from mice at days 3, 7 and 14 (day 14 not shown)
post-infection, whereupon pooled tissue from 4–5 mice per group
(wild type vs SarA-deficient) was analyzed for macrophage,
microglia and T cell markers (A) as well as neutrophil markers
(B), with representative histograms and isotype controls shown
here (three independent replicates performed).
(TIF)
Figure S4 There is no significant effect of extracellular
proteases on parenchymal spread of catheter-associated
infection. Infected catheters were removed, rinsed and sonicated
for quantification of viable bacteria associated with wild type
USA300 LAC (WT catheter), USA300 LACDsarA (SarA-
deficient catheter), extracellular protease deficient USA300
LAC (Protease-deficient catheter), or SarA and extracellular
protease deficient (SarA-Protease-deficient catheter) S. aureus.
The surrounding tissue was also homogenized for bacterial
culture. At all time points, the bacterial burdens adherent to the
catheters were 3–5 log higher than the corresponding brain
parenchyma, although this difference was not statistically signif-
icant in the SarA-deficient catheters at either time point nor the
SarA-Protease-deficient catheter at day 7 (p,0.05 for all other
groups and time points). Bacterial burdens in the brain
parenchyma were essentially equal, with the exception of a
statistically significant different between the parenchymal bacterial
titers in the wild type and protease-deficient catheters at day 7.
a=p,0.05 WT parenchyma vs catheter; b=p,0.05 Protease-
deficient parenchyma vs catheter; c=p,0.05 SarA-Protease-
deficient parenchyma vs catheter; d=p,0.05 WT vs Protease-
deficient parenchyma (n= 13–15 mice/group/time point).
(TIF)
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